Features of the Humoral Response to Infection, Vaccination, and Revaccination during COVID-19

IgM and IgG antibodies to the SARS-CoV-2 virus are detected in subjects who have recovered from COVID-19; IgM antibodies persist in a 1/3 of infected subjects up to 12 months from the moment of the disease, while IgG antibodies are present in the vast majority of cases (97%; medium and high levels a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kombarova, S. Yu., Aleshkin, A. V., Novikova, L. I., Bochkareva, S. S., Zatevalov, A. M., Mekhtiev, E. R., Mizaeva, T. E., Basov, A. A., Borisova, O. Yu., Likhanskaya, E. I., Voropaeva, E. A., Urban, Yu. N., Mitrokhin, S. D., Shkoda, A. S., Gushchin, V. A., Sinyavin, A. E., Nikiforova, M. A., Lebedin, Yu. S., Karaulov, A. V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Immunology and Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628323/
https://www.ncbi.nlm.nih.gov/pubmed/36322302
http://dx.doi.org/10.1007/s10517-022-05620-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628323/
https://www.ncbi.nlm.nih.gov/pubmed/36322302
http://dx.doi.org/10.1007/s10517-022-05620-1

Ejemplares similares